• Title of article

    Endoplasmic Reticulum Stress as a Therapeutic Target in Cancer: A mini review

  • Author/Authors

    Rahmati ، Marveh - Tehran University of Medical Sciences , Amanpour ، Saeid - Tehran University of Medical Sciences , Kharman-Biz ، Amirhossein - Tehran University of Medical Sciences , Moosavi ، Mohammad Amin - National Institute for Genetic Engineering and Biotechnology

  • Pages
    11
  • From page
    38
  • To page
    48
  • Abstract
    Perturbation of endoplasmic reticulum (ER) homeostasis leads to a stress condition described as “ER stress” which can induce the well-regulated program termed as unfolded protein response (UPR). The principal purpose of UPR is to reestablish the ER homeostasis. Some of the physiological and pathological situations that disrupt the homeostasis include hypoxia, glucose limitations, nutrient deprivation, low pH, genomic instability, and some cytotoxic compounds are frequently observed during the core formation and progression of tumors. These stressful microenvironments around the tumors affect the innate and adaptive immune responses. In addition, different immunoregulatory myeloid populations, like dendritic cells, myeloid-derived suppressor cells (MDSCs) and macrophages, accumulate in the tumor milieu and act as barriers to cancer immunotherapy. In these stressful situations, ER stress is usually induced to activate the UPR. Although the UPR mechanism is primarily a pro-survival process, preserved and/or prolonged excessive stress may induce cell apoptosis. Cancer and sustained ER stress may have modifications in ER stress mediated cell apoptosis and facilitate chronic inflammation and immune suppression within tumors. In this mini review, at first, we highlight the the role of UPR and its mediators in cancerous cells fate and then discuss their potential opportunities in cancer therapy.
  • Keywords
    ER stress response , unfolded protein response , cancer therapy
  • Journal title
    Basic and Clinical Cancer Research
  • Serial Year
    2017
  • Journal title
    Basic and Clinical Cancer Research
  • Record number

    2454077